SBN Share Price

Open 0.01 Change Price %
High 0.01 1 Day 0.00 0.00
Low 0.01 1 Week 0.00 0.00
Close 0.01 1 Month 0.00 0.00
Volume 334000 1 Year 0.00 0.00
52 Week High 3.77
52 Week Low 1.13
SBN Important Levels
Resistance 2 0.01
Resistance 1 0.01
Pivot 0.01
Support 1 0.01
Support 2 0.01
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
GPP 0.03 0.00%
PDN 0.06 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
GMR 0.01 0.00%
GMR 0.01 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
RMG 0.02 100.00%
RMG 0.02 100.00%
GME 0.03 50.00%
GME 0.03 50.00%
GME 0.03 50.00%
GME 0.03 50.00%
RHT 0.03 50.00%
RHT 0.03 50.00%
BMN 0.03 50.00%
More..
ASX Australia Top Losers Stocks
HOG 0.00 -100.00%
HOG 0.00 -100.00%
PCL 0.00 -100.00%
PCL 0.00 -100.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GTG 0.01 -50.00%
More..

Sun Biomedical Ltd (ASX: SBN)

SBN Technical Analysis 5
As on 30th Nov 2015 SBN Share Price closed @ 0.01 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.01 & Strong Buy for SHORT-TERM with Stoploss of 0.01 we also expect STOCK to react on Following IMPORTANT LEVELS.
SBN Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
SBN Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.sunbiomed.com
SBN Address
SBN
1 Walker Avenue
Level 2
West Perth, WA 6005
Australia
Phone: 61 8 9481 3860
Fax: 61 8 9321 1204
SBN Latest News
BRIEF-Dimerix Ltd appoints Kathy Harrison as CEO   Reuters   - 07th Nov 16
Dimerix positive interim analysis   NEWS.com.au   - 04th Oct 16
DMX 200 grows in promise for Dimerix   Finfeed (blog)   - 04th Oct 16
Interim Phase 2 Trial Data of Kidney Disease Drug DMX-200 to Be Reported by ...   CKD News   - 15th Jun 16
Dimerix Chief Scientist awarded Novartis Prize   Finfeed (blog)   - 15th Jun 16
Dimerix Bioscience Ltd surges in chronic kidney disease clinical trial   Proactive Investors Australia   - 06th Jun 16
Dimerix to progress its discovery platform with ARC Grant   Finfeed (blog)   - 09th May 16
Dimerix to meet with US FDA for new drug guidance   Finfeed (blog)   - 28th Apr 16
The search for a cure for chronic kidney disease: an interview with DXB ...   Finfeed (blog)   - 29th Mar 16
Dimerix launches $9m IPO to fund kidney therapy trial   The Australian Financial Review   - 15th Jun 14
Interactive Technical Analysis Chart Sun Biomedical Ltd ( SBN ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Sun Biomedical Ltd
SBN Business Profile
Sun Biomedical Limited does not have significant operations. It is in the process of identifying and assessing new investment opportunities with focus on biotechnology. Previously, the company was engaged in the development and sale of screening products for drugs of abuse. Sun Biomedical Limited is based in West Perth, Australia.